Feature article: Non-viral delivery promises a true alternative for cell therapy developers

Read our new feature article to learn how non-viral CRISPR editing systems are ushering in the next wave of cell therapies.

Produced in partnership with Nature Research Custom Media, this article features experts in the field of cell therapy development and explores a variety of topics including the advantages of non-viral CRISPR delivery over viral methods, methods researchers are using to overcome the low efficiency of non-viral delivery, and services currently available to help labs make the switch to non-viral delivery.